|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
76.050 -1.300 (-1.681%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 498,752 | 812.095% | 54,682 | 327,124 | 100,000 | 0 |
| Cost of Sales | (33,476) | 796.039% | (3,736) | (15,017) | (2,537) | -- |
| Gross Profit | 465,276 | 813.273% | 50,946 | 312,107 | 97,463 | -- |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (3,399,789) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (27,748) | |
| Share of Results of Asso. & JCEs | (566) | -66.667% | (1,698) | (2,097) | (8,811) | 0 | |
| Profit / (Loss) before Taxation | (75,664) | -77.108% | (330,524) | 48,145 | 2,524 | (3,630,431) | |
| Taxation | (3,135) | -48.429% | (6,079) | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (44) | -69.014% | (142) | (1,178) | 2,930 | 1,931 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (78,843) | -76.587% | (336,745) | 46,967 | 5,454 | (3,628,500) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (32,405) | -1.081% | (32,759) | (32,746) | (15,935) | 4,173 |
| Depreciation & Amortisation | 48,885 | 5.501% | 46,336 | 26,805 | 14,902 | 10,482 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -30.000 | -76.744% | -129.000 | 18.000 | 2.080 | -5,408.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 10.694 | -- | 9.426 | 12.062 | 13.016 | -- |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -78,843 |
| %Change | -76.587% |
| EPS / (LPS) | RMB -0.300 |
| NBV Per Share (¥) | RMB 10.694 |